Asian ethnicity and the prevalence of metabolic syndrome in the osteoarthritic total knee arthroplasty population

Journal of Arthroplasty

Volumn 25, Issue 3, 2010, Pages 416-419

  Gandhi, Rajiv ^a   Razak, Fahad ^a,b   Tso, Peggy ^a   Davey, J Roderick ^a   Mahomed, Nizar N ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Asians; Ethnicity; Knee osteoarthritis; Metabolic syndrome

Indexed keywords

AGED; ARTICLE; ASIAN; BODY MASS; CANADA; CONTROLLED STUDY; DIABETES MELLITUS; ETHNIC DIFFERENCE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; TOTAL KNEE REPLACEMENT;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ARTHROPLASTY, REPLACEMENT, KNEE; ASIAN CONTINENTAL ANCESTRY GROUP; CANADA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; KNEE PROSTHESIS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 77950519730     PISSN: 08835403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arth.2009.02.005     Document Type: Article

References (35)

1. Bray G.A., Bellanger T. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine 2006, 29:109.
2. Grundy S.M. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 2004, 89:2595.
3. Rutter M.K., Meigs J.B., Sullivan L.M., et al. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 2004, 110:380.
4. Wee C.C., Mukamal K.J., Huang A., et al. Obesity and C-reactive protein levels among white, black, and Hispanic US adults. Obesity 2008, 16:875.
5. Onat A., Can G., Hergenc G. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk. Metabolism 2008, 57:207.
6. Rojas-Rodriguez J., Escobar-Linares L., Garcia-Carrasco M., et al. The relationship between the metabolic syndrome and energy-utilization deficit in the pathogenesis of obesity-induced osteoarthritis. Med Hypotheses 2007, 69:860.
7. Singh G., Miller J.D., Lee F.H., et al. Prevalence of cardiovascular disease risk factors among US adults with self-reported osteoarthritis: data from the third National Health and Nutrition Examination Survey. Am J Manag Care 2002, 8(Suppl. 15):S383.
8. Conaghan P.G., Vanharanta H., Dieppe P.A. Is progressive osteoarthritis an atheromatous vascular disease?. Ann Rheum Dis 2005, 64:1539.
9. Pradhan A.D., Manson J.E., Rifai N., et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001, 286:327.
10. Kern P.A., Ranganathan S., Li C., et al. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol 2001, 280:E745.
11. Vozarova B., Weyer C., Hanson K., et al. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 2001, 9:414.
12. Toussirot E., Streit G., Wendling D. The contribution of adipose tissue and adipokines to inflammation in joint diseases. Curr Med Chem 2007, 14:1095.
13. Terlain B., Presle N., Pottie P., et al. Leptin: a link between obesity and osteoarthritis?. Bull Acad Natl Med 2006, 190:1421.
14. La Cava A., Alviggi C., Matarese G. Unraveling the multiple roles of leptin in inflammation and autoimmunity. J Mol Med 2004, 82:4.
15. Dumond H., Presle N., Terlain B., et al. Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum 2003, 48:3118.
16. Gualillo O. Editorial: further evidence for leptin involvement in cartilage homeostasis. Osteo Cartilage 2007, 15:857.
17. Simopoulou T., Malizos K.N., Iliopoulos D., et al. Differential expression of leptin and leptin's receptor isoform(Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect on cartilage metabolism. Osteo Cartilage 2007, 15:872.
18. Hoang K.C., Le T.V., Wong N.D. The metabolic syndrome in East Asians. J Cardiometab Syndr 2007, 2:276.
19. Enas E.A., Mohan V., Deepa M., et al. The metabolic syndrome and dyslipidemia among Asian Indians: a population with high rates of diabetes and premature coronary artery disease. J Cardiometab Syndr 2007, 2:267.
20. Nestel P., Lyu R., Low L.P., et al. Metabolic syndrome: recent prevalence in East and Southeast Asian populations. Asia Pac J Clin Nutr 2007, 16:362.
21. Razak F., Anand S.S., Shannon H., et al. Defining obesity cut points in a multiethnic population. Circulation 2007, 115:2111.
22. Meigs J.B., Wilson P.W., Nathan D.M., et al. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 2003, 52:2160.
23. Lorenzo C., Williams K., Hunt K.J., et al. The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 2007, 30:8.
24. World Health Organization Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation 1999, World Health Organization, Geneva.
25. Grundy S.M., Brewer H.B., Cleeman J.I., National Heart, Lung, and Blood Institute; American Heart Association, et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 2004, 24:e13.
26. Bellamy N., Buchanan W.W., Goldsmith C.H., et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988, 5:1833.
27. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287:356.
28. Aspden R., Scheven B., Hutchison J. Osteoarthritis as a systemic disorder including stromal cell differentiation and lipid metabolism. Lancet 2001, 357:1118.
29. Parvizi J., Pulido L., Purtill J.J., et al. Metabolic syndrome increases the risk for pulmonary embolism after joint arthroplasty. Abstract J Arthroplasty 2008, 23:327.
30. Ay C., Tengler T., Vormittag R., et al. Venous thromboembolism-a manifestation of the metabolic syndrome. Haematologica 2007, 92:374.
31. Ageno W., Prandoni P., Romualdi E., et al. The metabolic syndrome and the risk of venous thrombosis: a case-control study. J Thromb Haemost 2006, 4:1914.
32. Durina J., Remkova A. Prothrombotic state in metabolic syndrome. Bratisl Lek Listy 2007, 108:279.
33. Wang T.N., Huang M.C., Chang W.T., et al. G-2548A polymorphism of the leptin gene is correlated with extreme obesity in Taiwanese aborigines. Obesity 2006, 14:183.
34. Tong J., Fujimoto W.Y., Kahn S.E., et al. Insulin, C-peptide, and leptin concentrations predict increased visceral adiposity at 5- and 10-year follow-ups in nondiabetic Japanese Americans. Diabetes 2005, 54:985.
35. Peng X.D., Xie H., Zhao Q., et al. Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men. Clin Chim Acta 2008, 387:31.